Nureca’s Rs 100 crore will open for subscription on February 15, 2021. The shares of Nureca, which owns the Dr Trust brand, will be sold in the price band of Rs 396-400 apiece. The public offer will close on February 17, 2021. The shares are likely to be listed on BSE and NSE.
Investors can bid for a minimum one lot of 35 equity shares and in multiples thereafter, up to 14 lots. A total of up to 75 per cent of the issue will be reserved for qualified institutional buyers (QIB), up to 10 per cent for retail investors and remaining 15 per cent for the non-institutional category. Shares worth Rs 50 lakh will be reserved for eligible employees and these will be offered at a discount of Rs 20 per share.
The proceeds of the issue will be used for funding the company’s incremental working capital requirements and for general corporate purposes.
ITI Capital Ltd is the sole book running lead manager and Link Intime India Private is the registrar to the issue.
Nureca is engaged in the business of home healthcare and wellness products. It sells its products through its own website as well as online channel partners such as e-commerce players, distributors and retailers.